CARE Ratings Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

Current Price Action and Market Context

As of 2 Feb 2026, CARE Ratings Ltd closed at ₹1,600.65, down marginally by 0.29% from the previous close of ₹1,605.35. The stock traded within a range of ₹1,577.85 to ₹1,618.90 during the day, remaining well below its 52-week high of ₹1,964.80 but comfortably above the 52-week low of ₹1,057.65. This price action reflects a consolidation phase following a strong multi-year uptrend.

Comparatively, CARE Ratings has outperformed the Sensex over multiple time horizons. The stock delivered a 1-week return of 1.95% against the Sensex’s decline of 1.00%, and a 1-month gain of 0.95% while the Sensex fell 4.67%. Year-to-date, the stock is essentially flat (-0.01%) compared to the Sensex’s 5.28% decline. Over longer periods, CARE Ratings has significantly outpaced the benchmark, with a 1-year return of 17.18% versus 5.16% for the Sensex, a 3-year return of 163.55% against 35.67%, and a 5-year return of 231.23% compared to 74.40%. This strong relative performance underscores the company’s robust fundamentals and market positioning.

Technical Trend Shift: From Mildly Bullish to Mildly Bearish

The technical trend for CARE Ratings has recently shifted from mildly bullish to mildly bearish, signalling a cautious outlook among traders and investors. This change is reflected in the daily moving averages, which have turned mildly bearish, suggesting that short-term momentum is weakening. The stock’s price currently hovers near key moving average levels, indicating a potential test of support zones.

On the weekly timeframe, the Moving Average Convergence Divergence (MACD) remains bullish, indicating that medium-term momentum is still positive. However, the monthly MACD has turned mildly bearish, signalling that longer-term momentum is losing strength. This divergence between weekly and monthly MACD readings suggests a transitional phase where the stock may face increased volatility and directional uncertainty.

RSI and Momentum Oscillators

The Relative Strength Index (RSI) presents a mixed picture. On the weekly chart, the RSI is neutral with no clear signal, hovering around the mid-50s, which implies neither overbought nor oversold conditions. Conversely, the monthly RSI is bearish, indicating that the stock has experienced some selling pressure over the longer term. This bearish monthly RSI aligns with the mildly bearish monthly MACD, reinforcing the notion of a weakening longer-term momentum.

The Know Sure Thing (KST) oscillator also reflects this duality: bullish on the weekly timeframe but mildly bearish on the monthly. This suggests that while short-term momentum may still favour buyers, the broader trend is losing steam, warranting caution for investors looking for sustained upside.

Bollinger Bands and Price Volatility

Bollinger Bands on both weekly and monthly charts remain mildly bullish, indicating that price volatility is contained within an upward trending channel. The stock price is currently trading near the upper band on the weekly chart, which often signals short-term strength but also warns of potential resistance. The mildly bullish Bollinger Bands contrast with some bearish momentum indicators, highlighting the complex technical landscape CARE Ratings currently navigates.

Volume and Trend Confirmation Indicators

On balance volume (OBV) and Dow Theory signals currently show no clear trend on either weekly or monthly timeframes. The absence of volume confirmation suggests that recent price movements lack strong conviction from market participants. This lack of volume support may limit the sustainability of any short-term rallies and increases the risk of price reversals.

The Dow Theory readings also indicate no definitive trend, reinforcing the view that CARE Ratings is in a consolidation or transition phase. Investors should monitor volume patterns closely for signs of renewed buying interest or distribution.

Mojo Score and Analyst Ratings

CARE Ratings holds a Mojo Score of 64.0, which corresponds to a 'Hold' grade, upgraded from a previous 'Sell' rating as of 30 Jan 2026. This upgrade reflects improved technical and fundamental assessments, signalling that while the stock is not a strong buy, it is no longer considered a sell. The market capitalisation grade stands at 3, indicating a mid-tier valuation relative to peers in the capital markets sector.

This rating adjustment aligns with the mixed technical signals observed, suggesting that investors should adopt a balanced approach, weighing both upside potential and downside risks carefully.

Long-Term Performance and Sector Context

CARE Ratings operates within the capital markets sector, an area that has seen varied performance amid evolving economic conditions. The company’s long-term returns have been impressive, with a 10-year return of 32.45% compared to the Sensex’s 224.57%. While the stock’s decade-long performance trails the broader market, its shorter-term outperformance and consistent growth trajectory highlight its potential as a steady performer within its niche.

Investors should consider sector dynamics and macroeconomic factors that could influence capital markets companies, including regulatory changes, interest rate movements, and credit market conditions.

Investor Takeaway and Outlook

CARE Ratings Ltd currently presents a nuanced technical picture. The shift from mildly bullish to mildly bearish trends, combined with mixed signals from MACD, RSI, and moving averages, suggests that the stock is at a critical juncture. Short-term momentum indicators remain cautiously optimistic, but longer-term signals advise prudence.

Investors should watch for confirmation of trend direction through volume changes and price action around key moving averages. A sustained break below support levels could signal further downside, while a rebound supported by bullish weekly MACD and Bollinger Bands could reignite upward momentum.

Given the company’s solid fundamental backdrop and relative outperformance versus the Sensex, CARE Ratings remains a stock to monitor closely. The recent upgrade to a 'Hold' rating by MarketsMOJO reflects this balanced view, recommending neither aggressive buying nor selling at present.

In summary, CARE Ratings Ltd is navigating a phase of technical consolidation amid mixed momentum signals. Investors with a medium to long-term horizon may find value in the stock’s resilience and growth potential, while short-term traders should exercise caution and await clearer directional cues.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →